Cite

HARVARD Citation

    Everts‐Graber, J. et al. (2022). Reply to Potential Issues With the Use of Teriparatide After Denosumab‐Related Osteonecrosis of the Jaw. Journal of bone and mineral research. pp. 2046-2047. [Online]. 
  
Back to record